Are Atrial High-Rate Episodes Associated With Increased Risk of Ventricular Arrhythmias and Mortality?

This study evaluated the temporal association between atrial high-rate episodes (AHREs) and sustained ventricular arrhythmias (VAs) in a remotely monitored cohort with implantable cardioverter-defibrillators (ICD) with and/or without cardiac resynchronization therapy with a defibrillator (CRT-D). Cl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JACC. Clinical electrophysiology 2019-10, Vol.5 (10), p.1197-1208
Hauptverfasser: Vergara, Pasquale, Solimene, Francesco, D'Onofrio, Antonio, Pisanò, Ennio C., Zanotto, Gabriele, Pignalberi, Carlo, Iacopino, Saverio, Maglia, Giampiero, Della Bella, Paolo, Calvi, Valeria, Curnis, Antonio, Senatore, Gaetano, Biffi, Mauro, Capucci, Alessandro, Parisi, Quintino, Quartieri, Fabio, Caravati, Fabrizio, Giammaria, Massimo, Marini, Massimiliano, Rapacciuolo, Antonio, Manzo, Michele, Giacopelli, Daniele, Gargaro, Alessio, Ricci, Renato P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This study evaluated the temporal association between atrial high-rate episodes (AHREs) and sustained ventricular arrhythmias (VAs) in a remotely monitored cohort with implantable cardioverter-defibrillators (ICD) with and/or without cardiac resynchronization therapy with a defibrillator (CRT-D). Clinical relevance of AHREs in terms of VA rate and survival has not been outlined yet. This study analyzed data of patients with ICDs and CRT-Ds from the nationwide Home Monitoring Expert Alliance network. The cohort included 2,435 patients with a median follow-up of 25 months (interquartile range: 13 to 42 months) and age 70 years (range 61 to 77 years); 19.7% were women, 51.4% had coronary artery disease, and 45.2% had a CRT-D. There were 3,410 appropriate VA episodes; 498 (14.6%) were preceded by AHREs within 48 h; in 85.5% of this group, AHREs were still ongoing at episode onset. In a longitudinal analysis, the odds ratios (ORs) of experiencing any VA in a 30-day interval with AHREs versus intervals without AHREs were 2.35 (95% confidence interval [CI]: 1.86 to 2.97; p 
ISSN:2405-500X
2405-5018
DOI:10.1016/j.jacep.2019.06.018